• Kamila
  • Dermatolog og ansvarlig læge hos Cosmo Laser

    Jeg er uddannet Dermatolog og har klinisk erfaring fra både offentlige hospitaler, privathospitaler samt speciallægepraksis. Jeg har gennem +10 år udviklet praktiske og akademiske nichekompetencer inden for laser-operationer og laserbehandlinger. Disse kompetencer blev grundlagt under min ph.d.-afhandling. Produktet var et internationalt samarbejde mellem Harvard Medical School, Boston, USA og Bispebjerg Hospital.

Som hudlæge og laserekspert er jeg den ansvarlige læge hos Cosmo Laser og har ansvaret for at uddanne personalet samt være deres daglige sparringspartner.

Jeg er i klinikken flere gange ugentligt og konsulterer gerne kunder med særlige behov eller hensyn for at sikre et trygt behandlingsforløb.

Du kan læse om vores seneste rapporter for tilsynsbesøg for Cosmo – København, kan findes her.

Jeg er også overlæge på Adeas hud- og laserklinik samt sidder i speciallæge praksis.

Akademisk uddannelse

• 2015: Ph.d.-afhandling: ”Ablative Fractional Laser-mediated PDT – Perspectives for Basal Cell Carcinomas”. Internationalt samarbejde mellem Bisbjerg Hospital og Harvard Medical School, Boston, USA.


Erfaring

• 2020 - Cosmo Laser

• 2020 - Adeas Parken

• 2020 - Hudafdelingen, Gentofte Hospital

• 2020 - Speciallægepraksis Birkerød

• 2020-2020 Aleris-Hamlet Privathospital, Søborg

• 2015-2020 Speciallægeuddannelse på Dermatologisk afdeling Bispebjerg Universitets Hospital, Gentofte Hospital samt Hudklinikken Panoptikon, København V

• 2012-2015 Ph.d.-studerende, Dermatologisk afdeling Bispebjerg og Massachusetts General Hospital, Harvard Medical School, Boston, USA

• 2011 Forsker, Massachusetts General Hospital, Harvard Medical School, Boston, USA

• 2010-2011 Forskningsenheden Dermatologisk afdeling, Bispebjerg Hospital

• 2009-2010 Dermatologisk afdeling, Bispebjerg Hospital


Publikationer

• 2017: Haak CS, Hannibal J, Paasch U, Anderson RR, Haedersdal M. Laser-induced thermal coagulation enhances skin uptake of topically applied compounds Lasers Surg Med. 2017; 49(6): 582-591.

• 2016: Haak CS, Christiansen K, Erlendsson AM, Taudorf EH, Thaysen-Petersen D, Wulf HC, Hædersdal M. Ablative fractional laser enhances MAL-induced PpIX accumulation: Impact of laser channel density, incubation time and drug concentration. J Photochem Photobiol B. 2016 Jun; 159: 42-8.

• 2016: Erlendsson AM, Karmisholt KE, Haak CS, Stender IM, Haedersdal M. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.J Am Acad Dermatol. 2016; 74(4): 709-15.

• 2016: Vissing AC, Taudorf EH, Haak CS, Philipsen PA, Haedersdal M. Adjuvant eflornithine to maintain IPL-induced hair reduction in women with facial hirsutism: a randomized controlled trial. J Eur Acad Dermatol Venereol. J Eur Acad Dermatol Venereol. 2016; 30(2):314-9.

• 2015: Hermann GG, Mogensen K, Lindvold LR, Haak CS, Haedersdal M. Office-based transurethral devascularisation of low grade non-invasive urothelial cancer using diode laser. A feasibility study. Lasers Surg Med. 2015; 47(8): 620-5.

• 2015: Erlendsson AM, Taudorf EH, Eriksson AH, Haak CS, Zibert JR, Paasch U, Anderson RR, Haedersdal M. Ablative fractional laser alters biodistribution of ingenol mebutate in the skin. Arch Dermatol Res. 2015; 307(6): 515-22.

• 2015: Haak CS, Togsverd-Bo K, Thaysen-Petersen D, Wulf HC, Paasch U, Anderson RR, Haedersdal M. Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas – a randomized clinical trial. Br J Dermatol. 2015; 172(1): 215-22.

• 2014: Taudorf EH, Haak CS, Erlendsson AM, Philipsen PA, Anderson RR, Paasch U, Haedersdal M.Fractional ablative erbium YAG laser: Histological characterization of relationships between laser settings and micropore dimensions. Lasers Surg Med. 2014; 46(4): 281-9.

• 2012: Haak CS, Farinelli WA, Tam J, Doukas AG, Anderson RR, Hædersdal M. Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time. Lasers Surg Med. 2012; 44(10): 787-95.

• 2012: Haak CS, Bhayana B, Farinelli WA, Anderson RR, Haedersdal M. The impact of treatment density and molecular weight for fractional laser-assisted drug delivery. J Control Release 2012; 163(3): 335-41.

• 2012: Hedelund L, Haak CS, Togsverd-Bo K, Bogh MK, Bjerring P, Haedersdal M. Fractional CO2 laser resurfacing for atrophic acne scars: a randomized controlled trial with blinded response evaluation. Lasers Surg Med. 2012; 44(6): 447-52.

• 2012: Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Hædersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol. 2012; 166(6): 1262-9.

• 2012: Togsverd-Bo K, Paasch U, Haak CS, Haedersdal M.Lesion dimensions following ablative fractional laser treatment in non-melanoma skin cancer and premalignant lesions.Lasers Med Sci. 2012 May; 27(3): 675-9.

• 2011:Skovbølling Haak C,Illes M,Paasch U,Hædersdal M. Histological Evaluation of Vertical Laser Channels from Ablative Fractional Resurfacing: An Ex Vivo Pig Skin Model. Lasers Med Sci. 2011; 26(4): 465-71.

• 2010: Haak CS, Nymann P, Pedersen AT, Clausen HV, Feldt-Rasmussen U, Rasmussen AK, Main K, Haedersdal M. Hair Removal in Hirsute Women with Normal Testosterone Levels: A Randomized Controlled Trial of Long-pulsed Diode Laser versus Intense Pulsed Light. Br J Dermatol. 2010; 163(5): 1007-13.


Bogkapitler

• 2011: Haedersdal M, Haak CS. Hair Removal: Basics in Dermatological Laser Applications. Curr Probl Dermatol. Basel, Karger, 2011; 42: 111-121



Akademiske præsentationer

• Mar. 2019: Euro-PDT, Invited speaker: Photodynamic Therapy Combined with other Therapies to Enhance Patient Outcomes. Brussel, Belgien

• Apr. 2016: ASLMS 2016. Coagulation Zone Thickness influences Ablative Fractional Laser-assisted Drug Delivery. Boston, MA, USA 

• Sep. 2015: Ph.d.-forsvar: Ablative Fractional Laser-mediated Photodynamic Therapy - Perspectives for Basal Cell Carcinomas. Bispebjerg Hospital, København

• Nov. 2014: DDS efterårsmøde: Intensiveret PDT med fraktioneret laser – Hvad kan vi? Bispebjerg Hospital, København

• Dec. 2014: Lassendagen BBH: Ablative fractional laser enhance MAL-induced PpIX accumulation: Importance of laser density, incubation time and drug concentration. Bispebjerg Hospital, København

• Sep. 2014: Laser Innsbruck 2014: Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas – a randomized clinical trial. Innsbruck, Østrig

• Apr. 2014: ASLMS 2014: Ablative fractional laser and Methyl Aminolevulinate: Importance of laser densities, drug concentration and incubation time. Phoenix, AZ, USA

• Apr.2013: ASLMS 2013: Fractional Laser-assisted Delivery of Methyl Aminolevulinate: Impact of Laser Channel Depth and Incubation Time. Boston, MA, USA

• Apr.2013: ASLMS 2013: Conventional vs Fractional Laser-mediated Photodynamic Therapy of Difficult to Treat Basal Cell Carcinomas – a Randomized Clinical Trial. Boston, MA, USA

• Apr. 2012: ASLMS 2012: Fractional CO2Laser-assisted Drug Delivery is Affected by Laser Density and Molecular Weight. Kissimee, FL, USA

• Sep. 2011: Uddannelsesdag BBH: Fractional Laser Assisted Drug Delivery. Bispebjerg Hospital, København

• Nov.2010: Familien Hede Nielsens Fondens årsmøde: Ny behandling af hudkræft ” optimeret behandling med lys og laser et dansk – amerikansk samarbejde”. Horsens


Andet

Hede Nielsens Fond giver 500.000 kr. til forskning i behandling af hudkræft.